Next |
home / stock / espr / espr message board
Subject | By | Source | When |
---|---|---|---|
What do you make of this? | Johnny_C | investorshub | 06/22/2023 5:05:11 AM |
ESPR - B of A Securities Upgrades Esperion | findit | investorshub | 06/15/2023 12:31:13 PM |
$ESPR what do you make of this data? | keepemcloser | investorshub | 06/14/2023 1:16:55 AM |
What do you make of this? | Johnny_C | investorshub | 06/13/2023 1:16:35 AM |
should we be shorting? | Johnny_C | investorshub | 06/12/2023 8:23:54 AM |
are we finally gonna see some action | Johnny_C | investorshub | 06/11/2023 11:30:20 AM |
good read | Johnny_C | investorshub | 06/10/2023 7:28:27 AM |
MomentumIts now last trade up | Johnny_C | investorshub | 06/10/2023 5:11:02 AM |
$ESPR Good news recently, we should start to see this one move | T695 | investorshub | 06/08/2023 8:10:56 PM |
$ESPR The gaining last up | Johnny_C | investorshub | 06/06/2023 7:23:03 PM |
Good read | crudeoil24 | investorshub | 06/06/2023 6:47:57 AM |
Time for a bounce? | keepemcloser | investorshub | 06/04/2023 5:59:46 AM |
$ESPR great news | Paullee | investorshub | 06/01/2023 10:12:01 PM |
$ESPR The gaining | BuckeyeMike | investorshub | 06/01/2023 10:07:19 PM |
and the shorts continue | keepemcloser | investorshub | 05/29/2023 6:45:47 AM |
$ESPR Price now | Johnny_C | investorshub | 05/27/2023 3:46:20 PM |
Time for this to show some returns | keepemcloser | investorshub | 05/26/2023 2:30:59 AM |
$ESPR oh yeah news for the day | jbeloc | investorshub | 05/24/2023 8:55:58 PM |
are we finally gonna see some action | keepemcloser | investorshub | 05/24/2023 2:48:52 PM |
Good lord | Awl416 | investorshub | 03/15/2023 9:06:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., May 14, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced today that the U.S. Patent and Trademark Office (USPTO) issued a U.S. Patent Term Extension (PTE) certificate for bempedoic acid, which is contained in NEXLETOL ® (bempedoic acid) Tablets and NEXLIZET ...
Tuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up 467% Y/Y, surpassing the consens...